Prevention of type 2 diabetes

Area of Science:

• Endocrinology
• Public Health
• Preventive Medicine

Background:

• Global diabetes prevalence is increasing, with type 2 diabetes rising due to factors like longer lifespans and sedentary lifestyles.
• The World Health Organisation projects approximately 300 million diabetics by 2025, with a significant increase expected in Asia.
• Overweight and obesity are contributing factors to the escalating rates of type 2 diabetes worldwide.

Purpose of the Study:

• To highlight the critical need for diabetes prevention strategies.
• To compare the efficacy of lifestyle interventions versus pharmacological treatments in preventing type 2 diabetes.
• To emphasize the importance of promoting lifestyle modifications for diabetes prevention.

Main Methods:

• Review of findings from the Finnish Diabetes Prevention Study Group.
• Analysis of results from the Diabetes Prevention Programme.
• Examination of studies on pharmacological interventions like metformin, acarbose, and troglitazone.

Main Results:

• Lifestyle changes in overweight individuals with impaired glucose tolerance reduced type 2 diabetes incidence by 58%.
• Lifestyle intervention in individuals with impaired fasting glucose or impaired glucose tolerance also reduced diabetes risk by 58%.
• Metformin reduced type 2 diabetes risk by 31%, while acarbose and troglitazone showed benefits in high-risk individuals.

Conclusions:

• Lifestyle modifications are more effective than long-term drug therapy for diabetes prevention.
• Concerted efforts should focus on prevention to curb the worldwide increase in diabetes prevalence.
• Promoting lifestyle changes is essential for public health initiatives aimed at combating diabetes.